DICP OpenIR
Subject Area物理化学
nrestinal bacterial metabolite of naturally occurring 20(S)-protopanaxatriol ginsenosides is the inhibitor of CYP3A——a new biotransformation way with potential for clinical drug-druginteraction
杨凌; 刘勇
Conference NameThe 26th Symposium for Biomembrane-Drug Interaction
Conference Date2004-11-25
2004-11-25
Conference Place日本
Pages57/4
ISSN0031-6903
Department十八室
Funding Organization日本药学会
Other AbstractThe intestinal bacterial metabolites of ginsenosides are really responsible for the main pharmacological activities of ginseng. The purpose of this study was to find whether intestinal bacterial metabolites of ginsenosides possess influences on hepatic metabolic enzymes and to predict the potential for ginseng-prescription drug interactions. Utilizing the probe reaction of CYP3A activity, testosterone 6β-hydroxylation, the effects of derivatives of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol families on CYP3A activity in liver microsomes and cDNA-expressed human CYP3A4 were assayed. Our results showed that either in rat and human liver microsomes or in cDNA-expressed CYP3A4, ginsenosides exhibited a similar inhibition profile for testosterone 6β-hydroxylation activity. Ginsenosides from 20(S)-protopanaxadiol and 20(S)-protopanaxatriol family including Rb1, Rb2, Rc, Compound-K, Re, and Rg1 were no inhibitory effect, whereas the intestinal bacterial metabolite of 20(S)-protopanaxatriol ginsenosides, 20(S)-protopanaxatriol (Ppt), exhibited strong competitively inhibitory activity against CYP3A activity in human and rat liver microsomes and in cDNA-expressed CYP3A4. This finding demonstrates that naturally occurring ginsenosides have no inhibitory effects on CYP3A activities, yet their intestinal bacterial metabolite possesses the potential for inhibitory effects on CYP3A activities. It suggests that ginseng-derived products might result in significant ginseng-drug interactions via their intestinal bacterial metabolite.
Language中文
Document Type会议论文
Identifierhttp://cas-ir.dicp.ac.cn/handle/321008/111644
Collection中国科学院大连化学物理研究所
Corresponding Author杨凌
Recommended Citation
GB/T 7714
杨凌,刘勇. nrestinal bacterial metabolite of naturally occurring 20(S)-protopanaxatriol ginsenosides is the inhibitor of CYP3A——a new biotransformation way with potential for clinical drug-druginteraction[C],2004:57/4.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[杨凌]'s Articles
[刘勇]'s Articles
Baidu academic
Similar articles in Baidu academic
[杨凌]'s Articles
[刘勇]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[杨凌]'s Articles
[刘勇]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.